Cardiac conduction abnormalities during coronary arteriography in dogs: reduced effects of a new contrast medium.
D000081:Acetamides / Q000009:adverse effects; D000606:Amino Sugars / Q000009:adverse effects; D000790:Angiocardiography / Q000009:adverse effects*; D000818:Animals; D001145:Arrhythmias, Cardiac / Q000139:chemically induced*; D001549:Benzamides / Q000009:adverse effects; D003287:Contrast Media / Q000009:adverse effects*; D003973:Diatrizoate / Q000009:adverse effects / Q000031:analogs & derivatives; D004285:Dogs; D005944:Glucosamine / Q000009:adverse effects / Q000031:analogs & derivatives*; D006329:Heart Conduction System / Q000187:drug effects; D009994:Osmolar Concentration; D012492:Salts; D013012:Sorbitol / Q000009:adverse effects / Q000031:analogs & derivatives
D000081:Acetamides; D000606:Amino Sugars; D001549:Benzamides; D003287:Contrast Media; D012492:Salts; D003973:Diatrizoate; D013012:Sorbitol; D005944:Glucosamine